Prescription Drug Marketing Act - wikipedia Prescription Drug Marketing Act Prescription Drug Marketing Act of 1987 Long title An Act to amend the Federal Food, Drug, and Cosmetic Act to ban the reimportation of drugs produced in the United States, to place restrictions on the distribution of drug samples, to ban certain resales of drugs by hospitals and other health care facilities, and for other purposes. Enacted by the 100th United States Congress Effective April 22, 1988 Citations Public law 100 - 293 Statutes at Large 102 Stat. 95 Codification Acts amended Federal Food, Drug and Cosmetic Act Titles amended 21 U.S.C. : Food and Drugs U.S.C. sections amended 21 U.S.C. ch. 9 § § 331, 353, 381 Legislative history Introduced in the House as H.R. 1207 by John Dingell ( D -- MI ) on February 24, 1987 Committee consideration by House Committee on Energy and Commerce Passed the House on May 4, 1987 ( passed voice vote ) Passed the Senate on March 31, 1988 ( passed voice vote ) Signed into law by President Ronald Reagan on April 22, 1988 Major amendments Prescription Drug Amendments of 1992 P.L. 102 - 353, 106 Stat. 941 Regulation of therapeutic goods in the United States Prescription drugs Over-the - counter drugs Law Federal Food, Drug, and Cosmetic Act Comprehensive Drug Abuse Prevention and Control Act of 1970 Controlled Substances Act Prescription Drug Marketing Act Drug Price Competition and Patent Term Restoration Act Hatch - Waxman exemption Marihuana Tax Act Government agencies Department of Health and Human Services Food and Drug Administration Department of Justice Drug Enforcement Administration Process Drug discovery Drug design Drug development New drug application Investigational new drug Clinical trial ( Phase I, II, III, IV ) Randomized controlled trial Pharmacovigilance Abbreviated New Drug Application Fast track approval Off - label use International coordination International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Uppsala Monitoring Centre World Health Organization Council for International Organizations of Medical Sciences Single Convention on Narcotic Drugs Non-governmental organizations Institute of Medicine Research on Adverse Drug events And Reports NORML The Prescription Drug Marketing Act ( PDMA ) of 1987 ( P.L. 100 - 293, 102 Stat. 95 ) is a law of the United States federal government. It establishes legal safeguards for prescription drug distribution to ensure safe and effective pharmaceuticals. It 's designed to discourage the sale of counterfeit, adulterated, misbranded, subpotent, and expired prescription drugs. It was passed in response to the development of a wholesale sub-market ( known as the `` diversion market '' ) for prescription drugs. The PDMA was modified by the Prescription Drug Amendments of 1992 ( P.L. 102 - 353, 106 Stat. 941 ) on August 26, 1992. The U.S. Food and Drug Administration ( FDA ) issued regulations implementing the PDMA in 1990 ( 21 C.F.R. Part 205 ) and 1999 ( 21 C.F.R. Part 203 ). See also Food and Drug Administration ( FDA, USA ) Good Distribution Practice Inverse benefit law Regulation of therapeutic goods External links PDMA article FDA page on PDMA law, regulations and guidance Retrieved from `` https://en.wikipedia.org/w/index.php?title=Prescription_Drug_Marketing_Act&oldid=827538618 '' Categories : Pharmaceutical industry in the United States Pharmaceuticals policy United States federal controlled substances legislation United States federal health legislation United States statutes that abrogate Supreme Court decisions Talk About Wikipedia Edit links This page was last edited on 25 February 2018, at 08 : 48. About Wikipedia

Question: the act that restricted the sale of drugs by requiring a prescription was the
Answer: Prescription Drug Marketing Act (PDMA)